Prestige Biologics (334970)

KOSDAQ · 1,762 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

137.0B

PBR

1.01

52W

1K~3K

Prestige Biologics operates in the Pharmaceuticals sector.

Legal name: Prestige Biologics Co., Ltd.

As of the Aug 26, 2026 close, the market capitalization was 137.0 billion KRW, with a P/B of 1.01.

These figures can be verified in the DART filing (receipt no. 20250918000405).

2 applicable out of 8 items

매출액또는손익구조30%(대규모법인은15%)이상변동

Checks

2 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.1% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	매출액또는손익구조30%(대규모법인은15%)이상변동